
Meine Publikationsliste
Diabetes
-
Metformin: Antidiabetic actions from cells to tissues. Bailey CJ, Gwilt M, Brand KMG: Metabolism. 2026 Jun:179:156589. https://doi.org/10.1016/j.metabol.2026.156589
-
Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is. Campbell IW, Brand KMG, Gottwald-Hostalek U, Dettenbach J. Adv Ther. 2026 Jun;43(6):2421-2438. https://doi.org/10.1007/s12325-026-03592-6
-
Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes. Abusnana S, Sabbour H, Afandi B, Farghaly MNMH, MFarooqi MH, Hafidh K, Hassanein M, Jabbar A, Shehab A, RKalimat R, Brand KMG: Vasc Health Risk Manag. 2026 Feb 27:22:579970. https://doi.org/10.2147/VHRM.S579970
-
Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes. Brand KMG, Gottwald-Hostalek U, Andag-Silva A: Womens Health (Lond). 2025 Jan-Dec:21:17455057241311759. https://doi.org/10.1177/17455057241311759
-
Metformin in the treatment of hyperglycemia during pregnancy and periconception: guideline-informed expert recommendations from seven countries/states in the Asia-Pacific region. Nicodemus N, Novero V, Permadi W, Suastika K, Tan Tong Boon A, Deerochanawong C, Brand K, Hanindita MC, Alina Markova A: Curr Med Res Opin. 2025 Jul;41(7):1185-1196. https://doi.org/10.1080/03007995.2025.2496430
-
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study Brand KMG, Thoren R, Sõnajalg J, Boutmy E, Foch C, Schlachter J, KHakkarainen KM, Saarelainen L: BMJ Open Diabetes Res Care. 2022 Dec;10(6):e003056. https://doi.org/10.1136/bmjdrc-2022-003056
-
Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database. Brand KMG, Schlachter J, Foch C, Boutmy E 2022 Nov 4:18:1037-1047. https://doi.org/10.2147/TCRM.S372430
-
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. Schernthaner G, Brand K, Bailey C Metabolism. 2022 May;130:155160. https://doi.org/10.1016/j.metabol.2022.155160
-
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, Morin-Papunen L, Schlachter J; CLUE Study Group, Hakkarainen KM, Korhonen P.
BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002363. https://doi.org/10.1136/bmjdrc-2021-002363 -
Mechanisms of action of metformin with special reference to cardiovascular protection. Zilov AV, Abdelaziz SI, AlShammary A, Al Zahrani A, Amir A, Assaad Khalil SH, Brand K, Elkafrawy N, Hassoun AAK, Jahed A, Jarrah N, Mrabeti S, Paruk I.Diabetes Metab Res Rev. 2019 Oct;35(7):e3173. https://doi.org/10.1002/dmrr.3173
-
Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246. Brand K.Diabetes Care. 2020 Oct;43(10):e157-e158. https://doi.org/10.2337/dc20-0993
-
Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.Kidney Int. 2018 Jul;94(1):102-113. https://doi.org.10.1016/j.kint.2018.01.027
im Rahmen der Promotion
Entwicklung und Charakterisierung monoklonaler Antikörper zum Nachweis von Furanolabdanditerpenen und Triterpenen vom Oleanoltyp. Dissertation, Bonn 2002
Furanic labdane diterpenes from Marrubium vulgare L. (Lamiaceae) - investigation of analgesic effects. Brand, K., Schlüter, W., Schlemper, V., Cechinel-Filho, V. and Knöss, W. Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 1, 1999, 54
Antinociceptive effect of furanic labdane diterpenes Brand, K., Zampirollo, J., Schlemper, V., Cechinel-Vilho, V. and Knöss, W. Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 2 1999, 6
Monoclonal Antibodies: Tools in Isoprenois research Brand, K., Zündorf, I.,Dingermann, T., Knöss, W. Arch. Pharm. Pharm. Med. Chem. 334, Suppl. 2001